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Herceptin, a typical monoclonal antibody, was immobilized on the surface of CdSe/ZnS core-shell quantum dots (QDs) to enhance
their specific interactions with breast cancer cells (SK-BR3). The mean size of the core-shell quantum dots (28 nm), as determined
by dynamic light scattering, increased to 86 nm after herceptin immobilization.The in vitro cell culture experiment showed that the
keratin forming cancer cells (KB) proliferated well in the presence of herceptin-conjugated QDs (QD-Her, 5 nmol/mL), whereas
most of the breast cancer cells (SK-BR3) had died. To clarify the mechanism of cell death, the interaction of SK-BR3 cells with
QD-Her was examined by confocal laser scanning microscopy. As a result, the QD-Her bound specifically to the membrane of SK-
BR3, which became almost saturated after 6 hours incubation.This suggests that the growth signal of breast cancer cells is inhibited
completely by the specific binding of herceptin to the Her-2 receptor of SK-BR3 membrane, resulting in cell death.
1. Introduction
The development of noncytotoxic quantum dots (QDs) has
attracted considerable interest as luminescence probes in
biological andmedical research because of their some unique
optical and chemical properties [1], such as a tunable fluores-
cence wavelength according to size, a sharp and symmetrical
fluorescence peak, strong and stable emission, high quantum
yield, brightness, and photo stability [2–5]. QDs have several
advantages over traditional dyes and fluorescent proteins
used as imaging probes, such as tunable emission from visible
to infrared wavelengths, broader excitation spectra, and high
resistance to photo bleaching [6, 7]. On the other hand,
the potential applications of QDs in biology and medicine
are limited because of their toxic effects [8]. QDs contain
toxic components, such as cadmium or lead. Cd2+ and Pb2+
can be released from QDs to kill the cells [9]. Recently, a
number of techniques, such as a gold outer shell [10], targeted
ligand-like peptide [11], proteins [12, 13], and polymer coating
[14] have been developed to minimize the cytotoxicity of
QDs. Consequently, many approaches for transforming QDs
from hydrophobic to hydrophilic have been developed for
a range of biomedical applications. Accordingly, researchers
have also used noncytotoxic materials, such as polyethylene
glycol (PEG) and polymaleic anhydride salt-1-tetradecene, to
coat the surfaces of QDs [15].
Thus far, a range of surface coatings of QDs have been
explored including the conjugation of mercaptoacetic acid
[16], mercaptopropionic acid [17], mercaptobenzoic acid [18],
and biocompatible and chemically functionalizable inorganic
shells, such as silica or zinc sulfide [19]. These coatings can
guarantee the water solubility of QDs but cannot enhance
the biocompatibility significantly.Therefore, further coatings
with suitable water-soluble organic ligand/biomolecules are
necessary to enhance the biocompatibility of QDs. To that
end, QDs have been linked covalently with biorecognition
molecules, such as biotin [20], oleic acid [21], peptides [22],
bovine serum albumin [23], transferrin [24], antibodies [25],
and DNA [26].
Polymeric micelles have been studied extensively for the
solubilization of hydrophobic drugs and bioactive agents
because of their unique properties, including nanoscale size,
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high water solubility, high structural stability, high carrying
capacity of hydrophobic agents, and easy introduction of
functional moieties to the outer shell.The polymers generally
leave the fluorescent properties of QDs unchanged but allow
the introduction of other moieties to the QD surfaces [27].
CdSe/ZnS QD is a versatile core shell material with a wide
band gap of 3.37 eV and a rather large exciton binding energy
thatmakes the exciton state stable, even at room temperature.
Zinc is a very important trace element in humans [28] and
has been found to play an important part in many biological
systems [29–32]. Therefore, CdSe/ZnS core-shell QDs are
expected to be environmentally friendly andmore suitable for
bioimaging and cancer detection than CdSe QD.
In this study, breast cancer cells were targeted with
herceptin-conjugated quantum dots for cancer therapy and
diagnosis. Phospholipid-immobilized CdSe/ZnS core-shell
quantum dots (QDs) were prepared by a coupling reac-
tion of trioctylphosphine oxide-coated CdSe/ZnS core-shell
quantum dots with carboxylic acid-terminated PEG and
methoxy-terminated PEG. Herceptin was then introduced to
the surface of the QDs (QD-Her) to enhance the antitumor
effects of chemotherapeutic agents without increasing their
toxicity [33–36]. The surface properties of the QDs and QD-
Her were characterized by Fourier transform infrared (FT-
IR) spectroscopy, electron spectroscopy for chemical analy-
sis (ESCA), UV-Vis spectrometry, dynamic light scattering
(DLS), and zeta potential measurements. To evaluate the
cell compatibility and cytotoxicity of the QDs and QD-Her,
human breast cancer cells (SK-BR3) were cultured in the
presence ofQ-dots.The intracellular uptake ofQD-Her to the
cells was also observed by confocal laser scanningmicroscopy
(CLSM).
2. Materials and Methods
Trioctyl phosphine oxide (TOPO), trioctyl phosphine
(TOP), and hexadecylamine (HDA) were purchased from
Sigma-AldrichCo., USA.DSPE-PEG 2000 {1,2-distearoyl-sn-
glycero-3-phosphoethanolamine-N-[carboxy(polyethylene
glycol)-2000]} and PEG-2-PE {1,2-palmitoyl-sn-glycero-3-
phosphoethanolamine-N-[methoxy(polyethylene glycol)-
2000]} were purchased from Avanti Polar Lipids, USA. Her-
ceptin was obtained from Roche Pharma Ltd. (Basel, Swit-
zerland). Cell culture reagents, fetal bovine serum (FBS),Dul-
becco’smodified eaglemedium (DMEM, high glucose), peni-
cillin-streptomycin, trypsin/EDTA, and Dulbecco’s phos-
phate buffer saline (PBS) were supplied by Gibco BRL (Carl-
sbad, CA), and the SK-BR3 cells (breast cancer cells) were pu-
rchased from Korean Cell Line Bank.
2.1. Synthesis of CdSe/ZnS Core/Shell QDs. The synthesis of
CdSe/ZnS quantum dots was performed using recently repo-
rted methods [27, 35]. A mixture of 9mmol of trioctylphos-
phine oxide (TOPO), 7mmol of tetradecyl phosphonic acid
(TDPA), and 0.2 g of cadmium oxide (CdO) was heated to
240∘C for 20 minutes to obtain a clear solution. A solu-
tion containing 0.01 g of Se powder dissolved in 5mmol of
trioctylphosphine (TOP) was injected quickly into the hot
solution, and the reaction mixture was allowed to cool to
100∘C for the growth of CdSe nanocrystals. To obtain the
CdSe/ZnS nanoparticles, the solution was cooled to room
temperature and highly luminescent CdSe nanocrystals were
isolated and purified by centrifugation followed by precipita-
tion with methanol and finally dissolved in 5mL of toluene.
To obtain theCdSe/ZnS core-shell quantumdots, the pre-
cipitatedCdSe nanocrystals were dispersed in 2mLof TOP in
a three-necked flask. In addition, ZnS (0.092 g) was dissolved
in 2mmol TOP upon gentle heating. After cooling to room
temperature, the resultingmixturewas injected dropwise into
a reaction flask containing the core nanocrystal at 140∘C
for 6 hrs. After the addition was complete, the particles
were annealed at 90∘C for 6 hrs. Core-shell quantum dots of
various sizes were obtained by adjusting the concentration of
CdO and ZnS in TOP, as well as the corresponding injection
periods. The prepared CdSe/ZnS QDs were dissolved in
chloroform and purified further by centrifugation and double
reprecipitation from methanol.
2.2. Preparation of Hydrophilic CdSe/ZnS QDs. DSPE-PEG
and PEG-2 PE (2 : 8) were dissolved in 5mL of chloroform
(CHCl
3
) and 1mL of the mixture was transferred to a
250mL three neck round-bottom flask containing CdSe/ZnS
QDs in 5mL of chloroform. The clear solution was stirred
overnight under nitrogen. When the reaction was complete,
the chloroformwas removed by vacuum, and the residue was
mixed with 4mL of water and transferred to a centrifuge
tube. Subsequently, 40mL of water was added to the mixed
solution, and the precipitated product was separated by
centrifugation (3,000 rpm for 15min) and washed with water.
The precipitated product was dissolved in 10mL of methanol,
andwater was then added to ensure that polymer-coatedQDs
were suspended.
2.3. Immobilization of Herceptin on the Surface of CdSe/ZnS
QDs. The immobilization of herceptin on CdSe/ZnS (QD-
Her) was carried out by a reaction of water-soluble QDs with
herceptin, as shown in Figure 1. Water soluble QDs (18mg/
mL) and herceptin (108mg/mL) were added to a two-necked
round-bottom flask and dissolved in 10mL of PBS buffer (pH
6.0). EDC (1mmol) and NHS (1mmol) were added to the
reaction solution followed by stirring for 5 hrs at room tempe-
rature.The reaction solution was filtered to remove the preci-
pitate and then added to a dialysis membrane (MWCO:
100,000) in deionizedwatermedia for 24 h to remove the unr-
eacted EDC, NHS, and herceptin. Finally, the solution was
filtered through a 0.45 𝜇m membrane and dried for 24 hrs
under vacuum.
3. Results
3.1. Physical Characterization. Quantum dot nanoparticles
were ground with KBr powder, compressed into pellets, and
examined by FTIR (Jasco FTIR 300 E spectrometer) spec-
troscopy with a resolution of 4 cm−1. Transmission electron
microscopy (TEM, Philips, CM 200 TEM, applied operation
voltage; 120 kV) was used to observe the morphology of
























Figure 1: Schematic diagram showing the immobilization of herceptin on the CdSe/ZnS core-shell quantum dots (QD-Her).
the nanoparticles. To obtain the samples for the TEM obser-
vations, the particles were diluted with distilled water and
deposited on Formvar-coated 400 mesh copper grids. After
drying the nanoparticle-fluid thin film on the copper grid,
a thin carbon film, approximately 10–30 nm in thickness,
was deposited on the nanoparticles fluid film. The hydrody-
namic diameter and size distribution of the quantum dots
were determined by dynamic light scattering (DLS) using
a standard laboratory built light scattering spectrometer
using a BI90 particle sizer (Brookhaven Instruments Corp.,
Holtsville,NY).The systemhad a vertically polarized incident
light of 514.5 nm supplied by an argon ion laser (Lexel laser,
model 95). The UV-Vis absorption spectrum was recorded
from aqueous dispersions at room temperature using a
Hitachi U-3000 spectrophotometer.
3.2. Cell Culture. SK-BR3 (breast cancer cells) was used as
the target cell, and KB (epithelial cancer cells) was used
as the control cell line. The cells were cultured routinely
at 37∘C in a humidified atmosphere containing 5% CO
2
in
a polystyrene dish containing 10mL of McCOY medium
or DMEM medium, supplemented with 10% fetal bovine
serum and 1% penicillin streptomycin G sodium (PGS).
The medium was changed every third day. For subculture,
the cells were washed twice with PBS and incubated with
a trypsin-EDTA solution (0.25% trypsin, 1mM EDTA) for
10min at 37∘C to detach the cells. Complete media were
then added to the polystyrene dish at room temperature to
inhibit the effects of trypsin. The cells were washed twice
by centrifugation and resuspended in complete media for
reseeding and growing in new culture flasks. To observe the
morphology of cells, the cells were seeded at a concentration
of 1 × 105/mL in a 10mL Petri dish and incubated for 3 days
with QDs-or QD-Her-containingmedia at a concentration of
0.2mg/mL.Themorphology of adhered cells was observed by
optical microscopy (Nikon Eclipse TS100, Japan).
To examine the cellular uptake of nanoparticles via
fluorescence microscope and confocal laser microscope, the
cells were seeded at a concentration of 1 × 105/mL in a 10mL
Petri dish and incubated for 1 day. After 1 day, the medium
was replaced with QDs and QD-Her-containing media at a
particle concentration of 50𝜇g/mL and incubated for certain
time (1–6 hrs) for the internalization of the nanoparticles into
the cells. The cells were then washed three times with
Dulbecco’s PBS (D-PBS) and images were taken using flu-
orescence and confocal laser microscopes. The fluorescence
images were obtained using an Olympus IX70 fluorescence
microscope equipped with a cooled charge-coupled device
(CCD) camera. The images were processed using DVC
view software (version 2.2.8, DVC Company). A Zeiss
LSM 410 confocal laser scanning microscope (Brightness:
700 cd/mm2, Zeiss, Oberkochen, Germany) was used to
obtain the confocal images. The position and integrity of
the internalized QD-Her conjugates were evaluated by con-
focal microscopy using 4,6-diamidine-2-phenylindole dihy-
drochloride (DAPI, blue) as a marker, which stains the nuclei
of the cells. The cell nuclei were stained by the addition of
DAPI solution (10 𝜇L) with proper mixing and incubated
for 10min. To track the QD-Her nanoparticles, herceptin-
conjugated QDs and DAPI (488 nm) were added to the cells.
The stained cells were washed at least three times with 1mL
of fresh McCoy medium and images were then taken by
confocal laser microscopy [37].
The comparative proliferation of SK-BR3 andKB cells in a
medium containing QDs and QD-Her was determined using
aMTT (3-{4,5-dimethylthiazol-2yl}-2,5-diphenyltetrazolium
bromide) assay. Briefly, the SK-BR3 and KB cells were seeded
separately (1 × 105 cell/mL) on 24 well plates in the presence
of a cell culture medium. After 24 h, the culture medium was
replaced with fresh medium containing QDs and QD-Her at
a particle concentration of 200𝜇g/mL. After incubation for
1, 2, and 3 days, a 50𝜇L MTT solution (5mg/mL in PBS) was
added to each well and incubated in a humidified atmosphere
of 5% CO
2
at 37∘C for 4 h. After removing the medium, the
converted dye was dissolved in acidic isopropanol (0.04N
HCl-isopropanol) and kept for 30min in the dark at room
temperature. From each sample, the medium (100 𝜇L) was
taken, transferred to a 96-well plate, and subjected to the
ultraviolet measurements of the converted dye. This was
achieved at a wavelength of 570 nm on a kinetic microplate
reader. The experiment was repeated at least three times.
The phase contrast and fluorescence images of the cells
were obtained using a combined explorer system with a
motorized inverted fluorescence microscope (Carl Zeiss
LSM700, Germany), using the topographic images that can
be detected simultaneously.The cell proliferation experiment
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Figure 2: FT-IR spectra of the QDs (a), QD-Her (b), and herceptin
(c) measured using the KBr method.
was performed in triplicate and the results were expressed as
mean ± standard deviation (SD). Student’s t-test was used to
assess the statistical significant differences in the results. A 𝑃
value <0.05 was considered significant.
4. Discussions
4.1. Surface Characterization of Herceptin-Immobilized QDs.
The surface modification of QDs with herceptin was con-
firmed by FTIR, as shown in Figure 2. In the case of the QDs
spectrum, the introduction of DSPE-PEG 2000 to the surface
of the QDs was confirmed by observing the characteristic
peaks at 1700 and 3500 cm−1, as shown in Figure 2(a), which
was attributed to free carboxyl (–COOH) and hydroxyl (–
OH) groups [38, 39]. Again, after the reaction of the QDs
with herceptin, two new peaks at positions approximately
1648 cm−1 and 1540 cm−1 were observed in the spectrum of
QD-Her (Figure 2(b)), which were assigned to amide I (–
CO–NH–) and amide II (–CO–NH–) bonds, respectively,
indicating the successful immobilization of herceptin on the
surface of the QDs [29, 32].
Figures 3(a) and 3(b) present TEM images of theQDs and
QD-Her, respectively. The QDs have a spherical morphology
with ameandiameter of∼4.1 nm. Because of the small dimen-
sions and high surface energy of the particles, it was easy for
them to aggregate, as seen in Figure 3(a). On the other hand,
in the case of QD-Her, the particles had a mean diameter
of 4.5 nm, were spherical in shape, and showed significantly
less aggregation (Figure 3(b)). The larger particle size and
nonaggregated particles morphology was attributed to the
conjugation of herceptin on the surface of the QDs. Figure 4
shows the typical size and size distribution of the synthesized
QDs (Figure 4(a)) and QD-Her (Figure 4(b)) measured by
DLS. The mean size of the QDs as determined by DLS was
∼28 nm. On the other hand, the mean size of the QD-Her
was approximately 86 nm. The particle size, as determined
by DLS, was considerably larger than that determined by
TEM. This is because the DLS technique measures the mean
hydrodynamic diameter of the QDs core surrounded by
the organic and solvation layers, and this hydrodynamic
Table 1: Atomic percentage of QDs and QD-Her calculated from
the ESCA survey scan spectra.
Substrates Atomic (%)
C O N P
QDs 69.3 24.0 0.7 6.0
QD-Her 73.1 15.5 10.5 0.5
diameter is affected by the viscosity and concentration of
the solution. TEM, however, gives the diameter of the core
alone [29]. The synthesis of CdSe/ZnS core-shell QDs and
herceptin-immobilized QDs was also confirmed by UV-Vis
absorption spectroscopy, as shown in Figure 5. The QDs
showed an absorption onset at 526 nm (Figure 5(a)) and
after herceptin immobilization, it exhibited a red shift to
529 nm [31]. This red shift was caused by strong quantum
confinement due to the increase in particle size. In addition,
the peak at 529 nm attributed to the herceptin labels on the
surface of QDs, because of metal to ligand charge transfer
[34].
The immobilization of herceptin on the surface of QDs
was confirmed by ESCA, as shown in Figure 6. The QDs
showedpeaks for five elements corresponding toC1s (binding
energy, 284.0 eV) and O1s (binding energy, 526.5 eV), P2s, 2p
(binding energy, 197.0 eV, 132 eV), and N1s (binding energy,
397.0 eV), as shown in Figure 6(a). On the other hand, after
herceptin immobilization, the QD-Her showed three typical
peaks corresponding to C1s, O1s, and N1s. Table 1 lists the
chemical compositions of the QDs and QD-Her, which were
calculated from the ESCA survey scan spectra. In the case
of the QD-Her, the carbon content (73.1%) was higher than
in the QDs (69.3%). Furthermore, one new element, sulfur
(0.4%), was observed on the surfaces of the QD-Her, and
in the case of QD-Her, the nitrogen content increased from
0.7% to 10.5%, indicating the successful immobilization of
herceptin on the surface of theQDs.One possible explanation
for the reduction in the P2s, 2p, and S2p peaks is the
photoelectrons with energy loss and the increase in the
binding energy during immobilization with herceptin [40].
4.2. Evaluation of Cytotoxicity. Figure 7 shows the status of
the “Live/Dead” dye-stained SK-BR3 and KB cell cultured
in the presence of QDs and QD-Her for 1 and 3 days of
incubation.Using this qualitativemethod, the living and dead
cells were stained in green and red under the fluorescence
microscope, respectively. Figure 7 shows that all the KB cells
remained viable after 3 days of incubation, irrespective of the
presence or absence of nanoparticles. On the other hand, after
a culture of 1 and 3 days, in the presence of QD-Her, most of
the SK-BR3 cells had died, as shown in Figures 8(e) and 8(f).
On the other hand, most of the SK-BR3 cells remained viable
in the presence of theQDs and in the polystyrene culture dish
(Figures 7(a)–7(d)), but a nonsignificant number of cells were
dead in the QD-Her case. A possible explanation of this large
decrease in cell viability in the case of QD-Her is that intra-
cellularly delivered herceptin exhibits acute apoptotic activity
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Figure 4: Particle size distribution of the QDs (a) and QD-Her (b) measured by dynamic light scattering (DLS).





















Figure 5: UV-Vis absorption spectra of theQDs (a) andQD-Her (b)
in aqueous solution.
by interacting with several transcription factors related to
cell proliferation [39]. Previously, Bae et al. reported that
degradable heparin nanogels and heparin/chitosan polyelec-
trolyte nanocomplexes could effectively induce apoptosis via
receptor-mediated endocytosis through specific herceptin-
HER2 integrin interaction [39]. The endocytosed QD-Her
within the cells would release free herceptin molecules in
the cytoplasm by cleaving the QD-herceptin linkage under























Figure 6: ESCA survey scan spectra of theQDs (a) andQD-Her (b).
higher glutathione (GSH) concentration (20Mm) than the
extracellular level [41]. GSH is the most abundant reduc-
ing agent in the cytoplasm, facilitating the detachment of
herceptin from the QDs by breaking the PEG-herceptin
linkage. In addition, nanoparticles are taken up by the cells
through endocytosis, which disrupts the cell membrane [32],
or weak cell adhesive interactions with QDs promote apop-
tosis (programmed cell death). The core-shell nanoparticles
conjugated with herceptin may act as cellular markers and
target the receptors expressed on the cell surface with cellular









Figure 7: Fluorescence microscopy images of live and dead KB cells after culturing for 1 and 3 days in a polystyrene culture dish ((a), (b))
and in the presence of QDs ((b), (d)) and QD-Her ((e), (f)). The live and dead cells were stained and visualized in green and red, respectively,









Figure 8: Fluorescence microscopy image of the live and dead SK-BR3 cells after culturing for 1 and 3 days in a polystyrene culture dish
((a), (b)) and in the presence of QDs ((b), (d)) and QD-Her ((e), (f)). Live and dead cells were stained in green and red, respectively, under a
fluorescence microscope.






















Figure 9: MTT assay, absorbance as a measure of the cell proliferation of SK-BR3 cells cultured in the PS culture dish (the red bar), in the







Figure 10: Fluorescence images obtained from the culture of SK-BR3 cells for 1, 3, and 6 hrs in the presence of DAPI and QD-Her.
internalization. The receptors are highly regulated by the cell
surface proteins [37], which mediate the specific interactions
between the cells and their extracellular milieu, and they
are generally localized on the plasma membrane [33]. This
suggests that the cytotoxicity of QDs was improved by the
conjugation of DSPE-PEG and PEG-2-PE (Figures 7(c), 7(d))
and herceptin (Figures 7(e), 7(f)), as determined by the
viability of KB cells (see Figure 7).
Figure 9 shows the viability of SK-BR3 cells cultured for
1 and 3 days in the presence of QD-Her, as determined by
the MTT assay. After 1 and 3 days of incubation, the level of
SK-BR3 cell proliferation in the presence of QDs was similar
to that of the cells cultured in the absence of nanoparticles
(PS culture dish). On the other hand, cell proliferation
in the presence of QD-Her was significantly lower than
that of the QDs. Therefore, the CdSe/ZnS quantum dots
conjugatedwith herceptin could increase the death of SK-BR3
cells considerably compared to the CdSe/ZnS quantum dots
without herceptin.
4.3. Evaluation of Intracellular Uptake. The uptake of QD-
Her into the target cells was visualized by fluorescence
microscopy. Figure 10 shows fluorescence images obtained
from the cultured SK-BR3 cells that had been incubated for
up to 6 hrs in the presence QD-Her. During the cell culture
in the presence of QD-Her, a significant number of nanopar-
ticles were transported into the cells and emitted intense
fluorescence. This suggests that the QDs carrying herceptin
provide specific recognition signals for the nanoparticles to
facilitate internalization into the target cells (SK-BR3 cells).
The interaction of the herceptin from the QDs with the HER-
2 receptors expressed on the membrane surface of the SK-
BR3 cells might have contributed to the improvement in the
internalization of QD-Her into the cells, based on receptor-
mediated endocytosis [29]. Gan et al. reported similar results
[42]. They introduced a hepatocarcinoma binding peptide
(A54) onto the surface of the magnetite nanoparticles and
examined their interaction with hepatocellular carcinoma
cells in vitro by fluorescence microscopy. Internalization of
the herceptin-conjugated nanoparticles (QD-Her) into SK-
BR3 occurred. Breast cancer cells expressing HER-2 receptor
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were quite sensitive to herceptin. Figure 10 shows that her-
ceptin is an effective antibody, binding specifically to the
HER-2 receptor-bearing breast cancer cells. The internaliza-
tion of QD-Her into SK-BR3 cells was confirmed by confocal
laser microscopy to characterize the delivery of QD-Her
to the cytoplasm of the SK-BR3 cells. Figure 10 shows the
fluorescence image derived from the nucleus of the SK-
BR3 cells (DAPI, blue) and QD-Her internalized (green).
The cells were cultured in the presence of QD-Her at vari-
ous incubation times (Figure 10). Weak QD-Her conjugates
were observed in the fluorescence image (green color) after
1 hr (Figure 10(a)) and slightly higher fluorescence image
was observed after 3 hrs (Figure 10(b)). Intense fluorescence
image was noted after 6 hrs (Figure 10(c)). On the other hand,
the blue fluorescence image derived from the nuclei stained
with DAPI was strong after 1 hr incubation but it decreased
with increasing incubation time and almost disappeared after
6 hrs incubation. In particular, the interaction of SK-BR3with
QD-Her began after 1 hr incubation and was accelerated and
saturated after 6 hrs.The confocal microscopy images suggest
that the nanoparticle-mediated delivery of monoclonal anti-
bodies was achieved efficiently, resulting in cell death. The
mechanism of internalization involves endocytosis followed
by the release of herceptin-conjugated nanoparticles to the
cytoplasm [37]. This suggests that the growth signal of breast
cancer cells is inhibited completely by the specific binding of
the herceptin to the Her-2 receptor of SK-BR3 membrane,
resulting in cell death [38].
5. Conclusions
DSPE-PEG-coatedCdSe/ZnS core-shell quantumdots (QDs)
were conjugated successfully with the herceptin antibody.
Herceptin immobilized QDs (QD-Her) were confirmed by
FTIR and XPS. The QD-Her size determined by DLS was
∼86 nm.TheQD-Her had no cytotoxicity on the control cells
(KB) compared to the target cells (SK-BR3). QD-Her was
internalized selectively into the target cells (SK-BR3), and free
herceptin was released in the cytoplasm, which induced acute
apoptosis. The QD-Her nanoparticles were endocytosed by
breast cancer cells (SK-BR3) to a large extent via a receptor-
mediated mechanism, where herceptin conjugated on the
nanoparticles targets the HER-2 receptor expressed on the
membrane of the cancer cells [39]. Therefore, QD-Her has a
potential use in optical imaging and the treatment of breast
cancer cells.
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